November 16, 2023
AUTREY v. KENVUE INC. et al
Case Number:
3:23-cv-22435
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 17, 2023
Kenvue Should Have Raised FDA Probe Before IPO, Suit Says
Pharmaceutical company Kenvue Inc. was hit with a proposed class action alleging it failed to inform investors ahead of its initial public offering about a regulatory investigation into the effectiveness of phenylephrine, which can be found in company products including Sudafed.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login